KCNA2-Associated Hereditary Spastic Paraplegia: Clinical Characteristics and Rationale for Targeted Treatment.

Boßelmann CM, Vyhnalek M, Blichova Z, Novotna L, Meszarosova AU, Havránková P, Kuster E, Lauerer RJ, Hedrich UBS, Lyu H, Oosterloo M, Alber M, Schöls L, Müller-Schlüter K, Bischoff AT, Klopstock T, Koutsis G, Karadima G, Efthymiou S, Houlden H, Salazar-Villacorta A, Ellis CA, Scheper A, Gläser D, Haack TB, Wagner M, Zech M, Platzer K, Striano P, Syrbe S, Schüle R, Lerche H.

Mov Disord · 2026-10-07

DOI: 10.1002/mds.70555PMID: 42844944